Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
about
Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effectsParadoxical rise in blood pressure during propranolol treatmentPropranolol-induced depressionThe mechanism of action of tyramine on the blood vessels of the forearm in man.Modification of cardiovascular responses by propranolol.Are blood pressure surges associated with sympathetic stimulation aggravated by beta-adrenoceptor antagonist treatment?Noradrenaline producing phaeochromocytomas with absent pressor response to beta-blockade.Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.Sympathomimetic amine infusion after beta-adrenoceptor and parasympathetic blockade [proceedings]Clinical pharmacology of labetalol.Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline.Clinical and hemodynamic appraisal of beta adrenergic blocking drugs.Propranolol as an antihypertensive agent in children.Adrenalectomy abolishes antagonism of alpha-adrenoceptor-mediated hypotension by a beta-blocker in conscious rats.Malignant pheochromocytoma in a child: treatment with a combination of alpha- and beta-adrenergic blockade.Preoperative and operative management of patients with phaeochromocytoma.Effects of anaesthetic agents on pressor response to beta-blockers in the rat.
P2860
Q28265575-31951242-7CB9-4CBD-8629-69DE9091E307Q28340853-5779EA2A-49FE-4F6F-AD0D-F928B3571690Q28365619-32347B74-380D-4C9C-894A-BE5580DD1A77Q35039673-1D00D547-DD7D-4972-8CEF-AFC227734472Q36114638-1B9EF8DD-3337-4209-8B46-740231A3E23CQ36707389-CB6CED07-DED3-435C-9415-FFCA3310DD6DQ36767390-90804039-E735-4086-B85C-ADE656DAED33Q37978886-C1930356-FB51-45AE-949F-AB492C2D7262Q39251313-57F0B797-62BB-4E99-8A23-0A3466A69C88Q39296318-58A9ED79-6328-444B-8626-717EFDDF110FQ40025612-6F8A0B50-075A-441E-A43D-1C93D171F189Q40053278-55597194-BBFB-4CB2-8338-463CDE65BF36Q42109890-C015D66F-25A8-42ED-9AEC-143324660A6FQ42114517-CF4EED52-E7C1-45B6-B5C5-A256CC8F8257Q45216939-F9D8B62E-C245-41F3-A6AB-29264BBE4F32Q50327513-C606DF53-CE26-4E75-8774-454F74C72E32Q51700788-4C598A86-8D0D-4969-A81E-01201B489AB2
P2860
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
description
1966 nî lūn-bûn
@nan
1966 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1966 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1966年の論文
@ja
1966年論文
@yue
1966年論文
@zh-hant
1966年論文
@zh-hk
1966年論文
@zh-mo
1966年論文
@zh-tw
1966年论文
@wuu
name
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@ast
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@en
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@nl
type
label
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@ast
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@en
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@nl
prefLabel
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@ast
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@en
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@nl
P1476
Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.
@en
P2093
P304
P356
10.1016/0002-9149(66)90061-0
P407
P577
1966-09-01T00:00:00Z